This paper reports the course of remission of 64 major depressives, predominantly inpatients, whose course was followed longitudinally with repeated assessment. Remission was comparatively rapid for many of the subjects so that 70% had remitted by 6 months. Only 6% failed to remit by 15 months. Slower remission occurred in those subjects who were initially more severely ill and had longer episodes. Detailed examination at the time of remission revealed that residual symptoms reaching 8 or more on the Hamilton Depression Scale were present in 32% of subjects who remitted below major depression. The pattern was of mild typical depressive symptoms without major biological symptoms. Residual symptoms were more common in subjects with more severe initial depression, but were unrelated to other predictors including longer prior illness, dysthymia or lower dose of drug treatment during the index episode. There were weak associations with passive dependent personality traits, which might however have been reflections of persisting symptom presence. Neither remission nor residual symptoms were related to life stress. Residual symptoms were strong predictors of subsequent relapse. Residual symptoms comprise an important adverse outcome in depression which is common and has received comparatively little attention in the past.

This content is only available via PDF.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.